Upstate Active Clinical Trials
Study Title:A Phase-1, Double-blind, Randomized, Placebo-controlled Study to Assess the Antiviral Activity and Safety of AT-752 in a Dengue Human Challenge Model
What is the purpose of the study? (in Layman's terms, please describe the study)To test the effectiveness of the oral investigational product against dengue virus, which causes dengue fever, a problematic disease in the developing world and for deployed military personnel.
Upstate Institutional Review Board (IRB) Number:1846837
Patient Age Group:Adults
Principal Investigator:Stephen J Thomas
What is involved if I participate?
- How long is the study?
For each volunteer, 4 months. Visits during first 2 weeks are almost daily frequent, then become increasingly spaced out.
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Physical assessment, blood draws, echocardiogram, ECG, urine drug test
Where will the study take place?Global Health Research Unit, Upstate Community Campus (4900 Broad Rd. Syracuse), POB-North Suite 4U
Other Information:Ample compensation not only for parking but for volunteer's time.
Students welcome, but any healthy adult with a flexible schedule is encouraged to make an appointment for screening.
For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: Michelle D Klick